| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 37 | 2024 | 3402 | 3.740 |
Why?
|
| Brain Neoplasms | 11 | 2023 | 1215 | 2.860 |
Why?
|
| Meningitis, Bacterial | 3 | 2022 | 94 | 2.040 |
Why?
|
| Child Abuse | 5 | 2022 | 198 | 1.740 |
Why?
|
| Ganglioglioma | 3 | 2020 | 24 | 1.700 |
Why?
|
| Neuroimaging | 13 | 2023 | 319 | 1.640 |
Why?
|
| Radiation Injuries | 3 | 2018 | 141 | 1.540 |
Why?
|
| Proton Therapy | 3 | 2018 | 121 | 1.520 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2018 | 350 | 1.490 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2023 | 138 | 1.490 |
Why?
|
| Cranial Nerves | 2 | 2024 | 20 | 1.380 |
Why?
|
| Craniocerebral Trauma | 4 | 2022 | 139 | 1.350 |
Why?
|
| Astrocytoma | 3 | 2019 | 102 | 1.260 |
Why?
|
| Contrast Media | 7 | 2021 | 452 | 1.160 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2022 | 1977 | 1.150 |
Why?
|
| Supratentorial Neoplasms | 2 | 2020 | 37 | 1.140 |
Why?
|
| Sensitivity and Specificity | 11 | 2022 | 1998 | 1.080 |
Why?
|
| Infant | 31 | 2024 | 12219 | 1.030 |
Why?
|
| Retrospective Studies | 35 | 2024 | 15593 | 0.970 |
Why?
|
| Pons | 1 | 2024 | 31 | 0.960 |
Why?
|
| Hydrocephalus | 6 | 2024 | 235 | 0.950 |
Why?
|
| Sinus Thrombosis, Intracranial | 5 | 2024 | 48 | 0.950 |
Why?
|
| Child, Preschool | 30 | 2024 | 13733 | 0.910 |
Why?
|
| Gadolinium | 2 | 2021 | 102 | 0.870 |
Why?
|
| Muscle Weakness | 1 | 2024 | 82 | 0.870 |
Why?
|
| Ataxia | 2 | 2024 | 168 | 0.860 |
Why?
|
| Brain | 12 | 2024 | 2918 | 0.850 |
Why?
|
| Essential Tremor | 1 | 2024 | 89 | 0.850 |
Why?
|
| Child | 43 | 2024 | 23984 | 0.840 |
Why?
|
| Streptococcus agalactiae | 2 | 2022 | 105 | 0.820 |
Why?
|
| Female | 51 | 2024 | 64043 | 0.760 |
Why?
|
| Male | 48 | 2024 | 58941 | 0.750 |
Why?
|
| Encephalitis | 1 | 2022 | 108 | 0.750 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2019 | 164 | 0.720 |
Why?
|
| Humans | 76 | 2024 | 121122 | 0.700 |
Why?
|
| Diagnosis, Differential | 11 | 2022 | 1870 | 0.700 |
Why?
|
| Ear, Inner | 1 | 2020 | 52 | 0.690 |
Why?
|
| Deep Brain Stimulation | 1 | 2024 | 382 | 0.650 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 134 | 0.630 |
Why?
|
| Skull Fractures | 1 | 2018 | 42 | 0.620 |
Why?
|
| Joint Diseases | 1 | 2018 | 33 | 0.620 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2019 | 210 | 0.610 |
Why?
|
| Stroke | 6 | 2023 | 945 | 0.610 |
Why?
|
| Hemangioma, Capillary | 1 | 2017 | 17 | 0.590 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2017 | 5 | 0.590 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 266 | 0.590 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 190 | 0.580 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2017 | 19 | 0.570 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 140 | 0.570 |
Why?
|
| Cerebral Arteries | 1 | 2017 | 79 | 0.560 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 240 | 0.550 |
Why?
|
| Glioma | 1 | 2021 | 494 | 0.550 |
Why?
|
| Adolescent | 20 | 2024 | 18761 | 0.530 |
Why?
|
| Orbit | 2 | 2017 | 103 | 0.520 |
Why?
|
| Meningeal Neoplasms | 2 | 2017 | 172 | 0.520 |
Why?
|
| Blood Volume Determination | 1 | 2014 | 9 | 0.490 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 192 | 0.490 |
Why?
|
| Cranial Nerve Diseases | 2 | 2012 | 25 | 0.480 |
Why?
|
| Blood Volume | 1 | 2014 | 79 | 0.470 |
Why?
|
| Medulloblastoma | 3 | 2024 | 333 | 0.450 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 52 | 0.440 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 313 | 0.430 |
Why?
|
| Mutism | 2 | 2024 | 29 | 0.420 |
Why?
|
| Meglumine | 3 | 2018 | 15 | 0.420 |
Why?
|
| Infant, Newborn | 9 | 2024 | 7975 | 0.420 |
Why?
|
| Teratoma | 1 | 2013 | 125 | 0.410 |
Why?
|
| Organometallic Compounds | 3 | 2018 | 105 | 0.400 |
Why?
|
| Oculomotor Muscles | 1 | 2012 | 63 | 0.390 |
Why?
|
| Orbital Diseases | 1 | 2012 | 91 | 0.380 |
Why?
|
| Mitochondrial Diseases | 2 | 2024 | 133 | 0.380 |
Why?
|
| Cerebellar Diseases | 2 | 2022 | 75 | 0.380 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 233 | 0.370 |
Why?
|
| Cerebellar Neoplasms | 2 | 2024 | 278 | 0.350 |
Why?
|
| Hematoma, Subdural | 2 | 2019 | 21 | 0.310 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2008 | 6 | 0.300 |
Why?
|
| Chondrocalcinosis | 1 | 2008 | 11 | 0.300 |
Why?
|
| Optic Nerve Glioma | 2 | 2019 | 21 | 0.300 |
Why?
|
| Atlanto-Axial Joint | 1 | 2008 | 21 | 0.300 |
Why?
|
| Spinal Diseases | 2 | 2018 | 46 | 0.290 |
Why?
|
| Skull | 3 | 2022 | 143 | 0.260 |
Why?
|
| Spasms, Infantile | 2 | 2017 | 167 | 0.250 |
Why?
|
| Observer Variation | 2 | 2017 | 297 | 0.240 |
Why?
|
| Spinal Injuries | 2 | 2022 | 29 | 0.240 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2024 | 16 | 0.230 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.230 |
Why?
|
| Fever | 2 | 2024 | 291 | 0.230 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 8 | 0.230 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 284 | 0.230 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.230 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2023 | 27 | 0.220 |
Why?
|
| Hysterotomy | 1 | 2024 | 118 | 0.220 |
Why?
|
| Laparotomy | 1 | 2024 | 137 | 0.220 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 28 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 30 | 0.220 |
Why?
|
| MELAS Syndrome | 1 | 2023 | 33 | 0.220 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2024 | 49 | 0.220 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2023 | 5 | 0.220 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 31 | 0.210 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 30 | 0.210 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 70 | 0.210 |
Why?
|
| Facial Paralysis | 1 | 2022 | 37 | 0.210 |
Why?
|
| Cerebral Ventricles | 2 | 2023 | 81 | 0.210 |
Why?
|
| Optic Atrophy | 1 | 2023 | 47 | 0.210 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 35 | 0.210 |
Why?
|
| Neural Pathways | 1 | 2024 | 259 | 0.210 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 2787 | 0.210 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2022 | 31 | 0.200 |
Why?
|
| Diffuse Axonal Injury | 1 | 2022 | 10 | 0.200 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 10 | 0.200 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2022 | 8 | 0.200 |
Why?
|
| Middle Aged | 8 | 2024 | 25297 | 0.200 |
Why?
|
| Sphingosine | 1 | 2001 | 12 | 0.190 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 65 | 0.190 |
Why?
|
| Meningomyelocele | 1 | 2024 | 222 | 0.190 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2001 | 7 | 0.190 |
Why?
|
| Anemia, Sideroblastic | 1 | 2021 | 17 | 0.190 |
Why?
|
| Lysophospholipids | 1 | 2001 | 30 | 0.190 |
Why?
|
| Hemangioma | 1 | 2022 | 97 | 0.190 |
Why?
|
| Solvents | 1 | 2001 | 42 | 0.190 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 35 | 0.190 |
Why?
|
| Scalp | 1 | 2021 | 56 | 0.190 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2021 | 23 | 0.190 |
Why?
|
| Purpura | 1 | 2021 | 24 | 0.190 |
Why?
|
| Microcephaly | 1 | 2024 | 320 | 0.180 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2020 | 7 | 0.180 |
Why?
|
| Language Development Disorders | 1 | 2022 | 166 | 0.180 |
Why?
|
| Adaptation, Psychological | 1 | 2024 | 451 | 0.180 |
Why?
|
| Head | 2 | 2022 | 102 | 0.180 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 20 | 0.180 |
Why?
|
| Fetoscopy | 1 | 2024 | 425 | 0.180 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 351 | 0.180 |
Why?
|
| Neurovascular Coupling | 1 | 2019 | 10 | 0.170 |
Why?
|
| Streptococcus pneumoniae | 1 | 2022 | 371 | 0.170 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2023 | 221 | 0.170 |
Why?
|
| Adult | 9 | 2023 | 28389 | 0.170 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2019 | 34 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2019 | 30 | 0.170 |
Why?
|
| Occipital Lobe | 1 | 2019 | 32 | 0.170 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 267 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 171 | 0.160 |
Why?
|
| Leukocyte Count | 1 | 2019 | 245 | 0.160 |
Why?
|
| Sinusitis | 1 | 2020 | 117 | 0.160 |
Why?
|
| Iopamidol | 1 | 2018 | 5 | 0.160 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 13 | 0.160 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 26 | 0.160 |
Why?
|
| Gadolinium DTPA | 1 | 2018 | 48 | 0.160 |
Why?
|
| Gray Matter | 1 | 2018 | 29 | 0.150 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 58 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2021 | 290 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 4966 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 49 | 0.150 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2018 | 84 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 803 | 0.140 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 33 | 0.140 |
Why?
|
| Nystagmus, Pathologic | 1 | 2017 | 22 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2017 | 305 | 0.140 |
Why?
|
| Myelography | 1 | 2016 | 8 | 0.140 |
Why?
|
| Aged | 4 | 2024 | 18432 | 0.140 |
Why?
|
| Radiotherapy Dosage | 1 | 2017 | 186 | 0.140 |
Why?
|
| Escherichia coli | 1 | 2022 | 973 | 0.140 |
Why?
|
| Spinal Cord | 2 | 2023 | 290 | 0.140 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2016 | 40 | 0.140 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 189 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 226 | 0.130 |
Why?
|
| Time Factors | 2 | 2017 | 5976 | 0.130 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 74 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2017 | 110 | 0.130 |
Why?
|
| White Matter | 1 | 2018 | 176 | 0.130 |
Why?
|
| Optic Nerve | 1 | 2017 | 116 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3208 | 0.130 |
Why?
|
| Neck | 1 | 2016 | 134 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 798 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2023 | 1043 | 0.130 |
Why?
|
| Canavan Disease | 1 | 2014 | 1 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 219 | 0.120 |
Why?
|
| Goldenhar Syndrome | 1 | 2014 | 13 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2014 | 26 | 0.120 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2014 | 8 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 45 | 0.120 |
Why?
|
| Chemoradiotherapy | 1 | 2015 | 99 | 0.120 |
Why?
|
| Anticoagulants | 3 | 2024 | 581 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2019 | 932 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2015 | 178 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 6095 | 0.120 |
Why?
|
| Software | 1 | 2018 | 669 | 0.110 |
Why?
|
| Mass Screening | 1 | 2019 | 770 | 0.110 |
Why?
|
| Syndrome | 3 | 2022 | 1116 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2014 | 164 | 0.110 |
Why?
|
| Brain Concussion | 1 | 2016 | 213 | 0.110 |
Why?
|
| World Health Organization | 1 | 2013 | 104 | 0.110 |
Why?
|
| Incidence | 2 | 2024 | 2969 | 0.110 |
Why?
|
| Artifacts | 1 | 2013 | 99 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2014 | 106 | 0.110 |
Why?
|
| Seizures | 3 | 2024 | 872 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 469 | 0.100 |
Why?
|
| Spinal Cord Diseases | 1 | 2012 | 38 | 0.100 |
Why?
|
| Arteriovenous Fistula | 1 | 2012 | 55 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 429 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2055 | 0.100 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 104 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1055 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 441 | 0.090 |
Why?
|
| Prevalence | 1 | 2017 | 2352 | 0.090 |
Why?
|
| Young Adult | 3 | 2019 | 8645 | 0.080 |
Why?
|
| Anisotropy | 2 | 2019 | 117 | 0.080 |
Why?
|
| Paresthesia | 1 | 2008 | 7 | 0.080 |
Why?
|
| Odontoid Process | 1 | 2008 | 7 | 0.080 |
Why?
|
| Hypesthesia | 1 | 2008 | 10 | 0.080 |
Why?
|
| Ligaments, Articular | 1 | 2008 | 22 | 0.080 |
Why?
|
| Cerebellum | 2 | 2022 | 410 | 0.080 |
Why?
|
| Neck Pain | 1 | 2008 | 18 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2008 | 107 | 0.070 |
Why?
|
| Risk Factors | 2 | 2024 | 9617 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1779 | 0.070 |
Why?
|
| Pregnancy | 3 | 2024 | 6854 | 0.070 |
Why?
|
| Calcinosis | 1 | 2008 | 166 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2017 | 5858 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1677 | 0.070 |
Why?
|
| Skull Neoplasms | 1 | 2005 | 15 | 0.060 |
Why?
|
| Chordoma | 1 | 2005 | 17 | 0.060 |
Why?
|
| Mutation | 3 | 2023 | 5737 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 58 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 16 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 23 | 0.060 |
Why?
|
| Neurosurgery | 1 | 2005 | 77 | 0.060 |
Why?
|
| Skull Base | 1 | 2024 | 50 | 0.060 |
Why?
|
| Cerebral Aqueduct | 1 | 2023 | 10 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2023 | 24 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 39 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4473 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 4603 | 0.050 |
Why?
|
| Phenotype | 2 | 2024 | 4194 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 45 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2024 | 186 | 0.050 |
Why?
|
| Citrulline | 1 | 2023 | 84 | 0.050 |
Why?
|
| COUP Transcription Factor I | 1 | 2023 | 91 | 0.050 |
Why?
|
| Facial Nerve | 1 | 2022 | 25 | 0.050 |
Why?
|
| Cytarabine | 1 | 2023 | 99 | 0.050 |
Why?
|
| Decision Making | 1 | 2008 | 648 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 194 | 0.050 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 12 | 0.050 |
Why?
|
| Remission Induction | 1 | 2023 | 299 | 0.050 |
Why?
|
| Propranolol | 1 | 2022 | 128 | 0.050 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 296 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 145 | 0.050 |
Why?
|
| Chloroform | 1 | 2001 | 4 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 303 | 0.050 |
Why?
|
| Chromatography, Thin Layer | 1 | 2001 | 40 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2021 | 45 | 0.050 |
Why?
|
| Micelles | 1 | 2001 | 19 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2024 | 2871 | 0.050 |
Why?
|
| Brain Stem | 1 | 2022 | 118 | 0.050 |
Why?
|
| Emotions | 1 | 2024 | 362 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2022 | 212 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 73 | 0.050 |
Why?
|
| Time | 1 | 2021 | 90 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2024 | 11690 | 0.050 |
Why?
|
| Gestational Age | 1 | 2024 | 1086 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2023 | 721 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 890 | 0.040 |
Why?
|
| Research | 1 | 2022 | 254 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 58 | 0.040 |
Why?
|
| Ethanol | 1 | 2001 | 160 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2019 | 20 | 0.040 |
Why?
|
| Central Venous Pressure | 1 | 2018 | 24 | 0.040 |
Why?
|
| Temporal Lobe | 1 | 2019 | 113 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 91 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2018 | 96 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 864 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 662 | 0.040 |
Why?
|
| Emergencies | 1 | 2018 | 172 | 0.040 |
Why?
|
| Mitochondria | 1 | 2022 | 665 | 0.040 |
Why?
|
| Nerve Net | 1 | 2018 | 233 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2023 | 1421 | 0.030 |
Why?
|
| Temporomandibular Joint | 1 | 2014 | 9 | 0.030 |
Why?
|
| Ear Ossicles | 1 | 2014 | 3 | 0.030 |
Why?
|
| Ear Canal | 1 | 2014 | 8 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 221 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 286 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2372 | 0.020 |
Why?
|
| Foramen Magnum | 1 | 2005 | 5 | 0.020 |
Why?
|
| Plasmacytoma | 1 | 2005 | 7 | 0.020 |
Why?
|
| Meningioma | 1 | 2005 | 110 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 424 | 0.010 |
Why?
|